I am not saying you are wrong in your beliefs. I don’t know if there’s a definitive event that will let them know that the application has been submitted. I was lead to believe by people who are in the biotech investment community that a rolling submission could end with an approval of the application. That once all the back and forth between company and MHRA is done and MHRA is satisfied, they ‘could’ see an approval as the end result. I don’t know enough and the information I got was qualified with ‘could happen’. Either way I am fine with where we are at.
Market Data 
Markets 
AI
